tiprankstipranks
N4 Pharma PLC (GB:N4P)
LSE:N4P

N4 Pharma (N4P) Share Price & Analysis

2 Followers

N4P Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range0.37p - 2.07p
Previous Close0.45p
Volume92.22K
Average Volume (3M)767.31K
Market Cap
£4.89M
Enterprise Value3.92M
Total Cash (Recent Filing)£1.03M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)
Beta0.46
Sep 18, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding268,780,349
10 Day Avg. Volume2,128,462
30 Day Avg. Volume767,307
Standard Deviation0.38
R-Squared0.03
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)1.31
Price to Sales (P/S)1128519.63
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

32.11%0.00%0.00%67.89%
32.11%
Insiders
0.00% Other Institutional Investors
67.89% Public Companies and
Individual Investors

N4P FAQ

What was N4 Pharma PLC’s price range in the past 12 months?
N4 Pharma PLC lowest share price was 0.36p and its highest was 2.07p in the past 12 months.
    What is N4 Pharma PLC’s market cap?
    Currently, no data Available
    When is N4 Pharma PLC’s upcoming earnings report date?
    N4 Pharma PLC’s upcoming earnings report date is Sep 18, 2024 which is in 58 days.
      How were N4 Pharma PLC’s earnings last quarter?
      N4 Pharma PLC released its earnings results on Apr 23, 2024. The company reported -0.002p earnings per share for the quarter, missing the consensus estimate of N/A by -0.002p.
        Is N4 Pharma PLC overvalued?
        According to Wall Street analysts N4 Pharma PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does N4 Pharma PLC pay dividends?
          N4 Pharma PLC does not currently pay dividends.
          What is N4 Pharma PLC’s EPS estimate?
          N4 Pharma PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does N4 Pharma PLC have?
          N4 Pharma PLC has 394,780,330 shares outstanding.
            What happened to N4 Pharma PLC’s price movement after its last earnings report?
            N4 Pharma PLC reported an EPS of -0.002p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of N4 Pharma PLC?
              Currently, no hedge funds are holding shares in GB:N4P
              ---

              N4 Pharma Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -68.96%
              12-Months-Change

              Fundamentals

              Return on Equity
              -78.94%
              Trailing 12-Months
              Asset Growth
              -41.12%
              Trailing 12-Months

              Company Description

              N4 Pharma PLC

              N4 Pharma PLC is a United Kingdom-based specialist pharmaceutical company. The company is engaged in reformulating existing drugs and vaccines to improve their performance to benefit the patients. The group operates in one business segment, that of the development and commercialization of medicines via its delivery system called Nuvec.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Futura Medical
              Akanda Corp
              Nuformix Plc
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis